PDMA Gives Manufacturers New Pricing Power Over Wholesalers - NACDS
Executive Summary
FDA's Prescription Drug Marketing Act regulations would give manufacturers new pricing power over wholesalers, according to the National Association of Chain Drug Stores.
You may also be interested in...
PDMA Definition Of Authorized Distributor Is Too Restrictive, APhA Says
FDA should revise its definition of authorized distributor in the proposed final rule to the Prescription Drug Marketing Act to allow wholesalers without formal manufacturer agreements to qualify, the American Pharmaceutical Association suggests.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials